Low prevalence of TP53 mutations and MDM2 amplifications in pediatric rhabdomyosarcoma

Sarcoma

Volumn 2012, Issue , 2012, Pages

  Ognjanovic, Simona ^a,b,c   Martel, Ghyslaine ^d   Manivel, Carlos ^c   Olivier, Magali ^d   Langer, Erica ^a   Hainaut, Pierre ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN MDM2; PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CODON; DNA ISOLATION; EMBRYO; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GERM LINE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SCHOOL CHILD; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84859759052     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2012/492086     Document Type: Article

References (36)

1. Gurney J. G., Young J. L., Roffers S. D., Smith M. A., Bunin G. R., Soft Tissue Sarcomas 2005 Bethesda, Md, USA National Cancer Institute
2. Pappo A., Pediatric Bone and Soft Tissue Sarcomas 2006 Heidelberg, Germany Springer
3. Ognjanovic S., Linabery A. M., Charbonneau B., Ross J. A., Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 19752005 Cancer 2009 115 18 4218 4226
4. Barr F. G., Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma Oncogene 2001 20 40 5736 5746 (Pubitemid 32928111)
5. Barr F., Meyer W. H., Rhabdomyosarcoma: An Overview of Biology, Clinical Features and the Current Children's Oncology Group Studies 2008 Alexandria, VA, USA American Society for Clinical Oncology
6. Petitjean A., Achatz M. I. W., Borresen-Dale A. L., Hainaut P., Olivier M., TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes Oncogene 2007 26 15 2157 2165 (Pubitemid 46536647)
7. Olivier M., Eeles R., Hollstein M., Khan M. A., Harris C. C., Hainaut P., The IARC TP53 database: new online mutation analysis and recommendations to users Human Mutation 2002 19 6 607 614 (Pubitemid 34556481)
8. Francisco G., Menezes P. R., Eluf-Neto J., Chammas R., Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies International Journal of Cancer 2011 129 4 920 930
9. Dumont P., Leu J. I. J., Della Pietra A. C., George D. L., Murphy M., The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nature Genetics 2003 33 3 357 365 (Pubitemid 36278852)
10. Bougeard G., Baert-Desurmont S., Tournier I., Vasseur S., Martin C., Brugieres L., Chompret A., Bressac-De Paillerets B., Stoppa-Lyonnet D., Bonaiti-Pellie C., Frebourg T., Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome Journal of Medical Genetics 2006 43 6 531 533 (Pubitemid 43927330)
11. Bond G. L., Hu W., Bond E. E., Robins H., Lutzker S. G., Arva N. C., Bargonetti J., Bartel F., Taubert H., Wuerl P., Onel K., Yip L., Hwang S. J., Strong L. C., Lozano G., Levine A. J., A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans Cell 2004 119 5 591 602 (Pubitemid 39535748)
12. Bond G. L., Hu W., Levine A., A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect Cancer Research 2005 65 13 5481 5484 (Pubitemid 40911143)
13. Castresana J. S., Rubio M. P., Gomez L., Kreicbergs A., Zetterberg A., Barrios C., Detection of TP53 gene mutations in human sarcomas European Journal of Cancer Part A 1995 31 5 735 738
14. Das P., Kotilingam D., Korchin B., Liu J., Yu D., Lazar A. J., Pollock R. E., Lev D., High prevalence of p53 exon 4 mutations in soft tissue sarcoma Cancer 2007 109 11 2323 2333 (Pubitemid 46801564)
15. Felix C. A., Kappel C. C., Mitsudomi T., Nau M. M., Tsokos M., Crouch G. D., Nisen P. D., Winick N. J., Helman L. J., Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma Cancer Research 1992 52 8 2243 2247
16. Kusafuka T., Fukuzawa M., Oue T., Komoto Y., Yoneda A., Okada A., Mutation analysis of p53 gene in childhood malignant solid tumors Journal of Pediatric Surgery 1997 32 8 1175 1180 (Pubitemid 27475893)
17. Latres E., Drobnjak M., Pollack D., Oliva M. R., Ramos M., Karpeh M., Woodruff J. M., Cordon-Cardo C., Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas American Journal of Pathology 1994 145 2 345 355 (Pubitemid 24245835)
18. Mulligan L. M., Matlashewski G. J., Scrable H. J., Cavenee W. K., Mechanisms of p53 loss in human sarcomas Proceedings of the National Academy of Sciences of the United States of America 1990 87 15 5863 5867
19. Nawa G., Miyoshi Y., Yoshikawa H., Ochi T., Nakamura Y., Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours British Journal of Cancer 1999 80 8 1185 1189 (Pubitemid 29264078)
20. Stratton M. R., Moss S., Warren W., Patterson H., Clark J., Fisher C., Fletcher C. D. M., Ball A., Thomas M., Gusterson B. A., Cooper C. S., Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene Oncogene 1990 5 9 1297 1301
21. Takahashi Y., Oda Y., Kawaguchi K. I., Tamiya S., Yamamoto H., Suita S., Tsuneyoshi M., Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma Modern Pathology 2004 17 6 660 669 (Pubitemid 38715488)
22. Taylor A. C., Shu L., Danks M. K., Poquette C. A., Shetty S., Thayer M. J., Houghton P. J., Harris L. C., P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines Medical and Pediatric Oncology 2000 35 96 103
23. Toguchida J., Yamaguchi T., Ritchie B., Beauchamp R. L., Dayton S. H., Herrera G. E., Yamamuro T., Kotoura Y., Sasaki M. S., Little J. B., Weichselbaum R. R., Ishizaki K., Yandell D. W., Mutation spectrum of the p53 gene in bone and soft tissue sarcomas Cancer Research 1992 52 22 6194 6199
24. Wrl P., Taubert H., Bache M., Kroll J., Meye A., Berger D., Siermann A., Holzhausen H. J., Hinze R., Schmidt H., Rath F. W., Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors International Journal of Cancer 1996 69 4 317 323 (Pubitemid 26298298)
25. Biernat W., Kleihues P., Yonekawa Y., Ohgaki H., Amplification and overexpression of MDM2 in primary (de novo) glioblastomas Journal of Neuropathology and Experimental Neurology 1997 56 2 180 185 (Pubitemid 27461181)
26. El Hallani S., Marie Y., Idbaih A., Rodero M., Boisselier B., Laigle-Donadey F., Ducray F., Delattre J. Y., Sanson M., No association of MDM2 SNP309 with risk of glioblastoma and prognosis Journal of Neuro-Oncology 2007 85 3 241 244 (Pubitemid 350142512)
27. Menin C., Scaini M. C., De Salvo G. L., Biscuola M., Quaggio M., Esposito G., Belluco C., Montagna M., Agata S., D'Andrea E., Nitti D., Amadori A., Bertorelle R., Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status Journal of the National Cancer Institute 2006 98 4 285 288 (Pubitemid 43264712)
28. Schneider-Stock R., Boltze C., Peters B., Szibor R., Landt O., Meyer F., Roessner A., Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer Neoplasia 2004 6 5 529 535 (Pubitemid 39411089)
29. Tommiska J., Eerola H., Heinonen M., Salonen L., Kaare M., Tallila J., Ristimki A., Von Smitten K., Aittomki K., Heikkil P., Blomqvist C., Nevanlinna H., Breast cancer patients with p53 pro72 homozygous genotype have a poorer survival Clinical Cancer Research 2005 11 14 5098 5103 (Pubitemid 41003693)
30. Kato S., Han S. Y., Liu W., Otsuka K., Shibata H., Kanamaru R., Ishioka C., Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8424 8429 (Pubitemid 36842561)
31. Diller L., Sexsmith E., Gottlieb A., Li F. P., Malkin D., Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma Journal of Clinical Investigation 1995 95 4 1606 1611
32. Castrén K., Ranki A., Welsh J. A., Vhkangas K. H., Infrequent p53 mutations in arsenic-related skin lesions Oncology Research 1998 10 9 475 482 (Pubitemid 128740441)
33. Vhkangas K. H., Bennett W. P., Castrén K., Welsh J. A., Khan M. A., Blmeke B., Alavanja M. C.R., Harris C. C., p53 and K-ras mutations in lung cancers from former and never-smoking women Cancer Research 2001 61 11 4350 4356 (Pubitemid 32685758)
34. Ognjanovic S., Oliver M., Bergemann T. L., Hainaut P., Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database Cancer 2012 118 5 1387 1396
35. Leach F. S., Tokino T., Meltzer P., Burrell M., Oliner J. D., Smith S., Hill D. E., Sidransky D., Kinzler K. W., Vogelstein B., p53 Mutation and MDM2 amplification in human soft tissue sarcomas Cancer Research 1993 53 10 2231 2234 (Pubitemid 23156805)
36. Oliner J. D., Kinzler K. W., Meltzer P. S., George D. L., Vogelstein B., Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 1992 358 6381 80 83